Physician profile
Robert J Chilton
NPI 1538276514
$1,291,784.58
in general payments reported to CMS, 2019-2025
42 companies · $143K in 2025
The $143K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227K · 2020: $148K · 2021: $249K · 2022: $210K · 2023: $170K · 2024: $146K · 2025: $143K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $383K · Travel and Lodging: $59K · Food and Beverage: $8,574 · Consulting Fee: $7,738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $382,581.39 |
| Travel and Lodging | $59,024.03 |
| Food and Beverage | $8,573.93 |
| Consulting Fee | $7,737.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $378,251.92 | 2019-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $289,780.85 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $183,108.47 | 2019-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170,729.48 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $50,624.46 | 2019-2024 | Farxiga |
| Boehringer Ingelheim South Africa (Pty) Ltd | $40,831.85 | 2019-2020 | |
| Boehringer Ingelheim Mena (Scientific Office) Fz-LLC | $28,785.00 | 2019 | |
| Boehringer Ingelheim International Gmbh | $26,654.19 | 2019-2023 | Jardiance |
| Boehringer Ingelheim (Phil.) INC. | $22,850.00 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $14,088.00 | 2019-2020 | |
| Eli Lilly and Company | $12,620.00 | 2021-2024 | Jardiance |
| Regeneron Pharmaceuticals, INC. | $12,415.62 | 2019 | |
| Amgen INC. | $10,101.76 | 2019-2024 | Repatha |
| Corcept Therapeutics | $9,094.05 | 2023-2025 | Korlym |
| Amarin Pharma, INC. | $8,318.66 | 2022-2023 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dr.Reddy'S Laboratories,INC. | $7,800.00 | 2023-2024 | |
| Boehringer Ingelheim, Unipessoal, Lda. | $7,082.92 | 2019 | |
| Boehringer Ingelheim Singapore Pte. Ltd. | $6,700.00 | 2020-2021 | |
| Medtronic, INC. | $3,986.04 | 2021-2025 | Resolute Onyx, Onyx Frontier, Acist Rxi System |
| Abbott Laboratories | $3,348.29 | 2020-2025 | Gallant, Dragonfly Opstar, Pressurewire |
| Abiomed | $735.37 | 2019-2025 | Impella |
| Biotronik INC. | $608.79 | 2019-2025 | Pulsar-18 T3, Passeo-18, Orsiro Mission |
| Medtronic Vascular, INC. | $550.52 | 2019-2020 | |
| Angiodynamics, INC. | $439.92 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $394.61 | 2019-2024 | Sq-Rx Pulse Generator |
| Heartflow, INC. | $277.86 | 2022-2023 | Ffrct |
| Novartis Pharmaceuticals Corporation | $252.23 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.73 | 2019-2024 | Lifevest |
| Shockwave Medical, INC | $147.43 | 2021-2025 | |
| Livanova USA, INC. | $146.64 | 2019-2020 | |
| Teleflex LLC | $137.02 | 2025 | Chocolate, Manta, Guideliner |
| Lexicon Pharmaceuticals, INC. | $129.25 | 2024-2025 | |
| Novo Nordisk As | $124.67 | 2023 | |
| Janssen Scientific Affairs, LLC | $122.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.93 | 2021 | |
| Inari Medical, INC. | $100.22 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ekos Corporation | $64.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.00 | 2020 | |
| Impulse Dynamics (USA) INC. | $23.34 | 2023 | Optimizer |
| Lantheus Medical Imaging, INC. | $20.57 | 2022 | |
| Philips North America LLC | $17.16 | 2019 | |
| Zoll Circulation INC | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Chilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.